Frequencies of different behaviours (Compartment Changes, Escape Attempts, Stimulus Orientation, Stimulus Approach, Stimulus Contact, Grunting, Barking, Excretion), the minimum dis... حسب Sara Hintze (3216885)

الموضوعات:

Image 3_Significance of LRFN4 in prognosis and tumor microenvironment of lung adenocarcinoma.tif حسب Nana Wang (533812)

Image 2_Significance of LRFN4 in prognosis and tumor microenvironment of lung adenocarcinoma.tif حسب Nana Wang (533812)

Image 1_Significance of LRFN4 in prognosis and tumor microenvironment of lung adenocarcinoma.jpeg حسب Nana Wang (533812)

Expression of proteins significantly correlated with stereotypy severity in CD1 Mice (n = 28). حسب Kendall M. Coden (18516237)

"…Expression of 7 proteins significantly correlated with stereotypy severity in CD1 mice. …"

Changes in Mf (A and B) CFA (C and D) prevalence at baseline, 1, 2 and 3 years after starting MDA. حسب Michael C. Payne (2664379)

الموضوعات:

Comparative analysis of macronutrient compositions between baseline and end of intervention (*p < 0.05, ^ns Non-significant results). حسب Duc Tran Quang (20564967)

Comparative analysis of caloric intake between baseline and end of intervention (*p < 0.05, ^ns Non-significant results). حسب Duc Tran Quang (20564967)

Results of RF regression model validation and significance of influencing factors (desert area change and spatiotemporal characteristics of ERI). حسب Mingyue Sun (4638535)

(a) Average absolute percentage relative error (AAPRE), and, (b) Coefficient of determination (R²) of the models. حسب Fahd Saeed Alakbari (10701871)

الموضوعات:

AUC of various models to predict imeglimin efficacy for liver function evaluated by ROC curves. حسب Naruyoshi Gyoutoku (22537831)

الموضوعات:

Logistic regression analysis to predict the efficacy for liver function. حسب Naruyoshi Gyoutoku (22537831)

الموضوعات:

Comparison in baseline variables between efficacy group and non-efficacy group. حسب Naruyoshi Gyoutoku (22537831)

الموضوعات:

Comparison of ALT (A), AST (B), and Fib-4 index (C) before and after imeglimin treatment in ALT ≥ 25 IU/L and ALT < 25IU/L groups. حسب Naruyoshi Gyoutoku (22537831)

الموضوعات:

Clinical characteristics at baseline and at the end of the study. حسب Naruyoshi Gyoutoku (22537831)

الموضوعات:

PRISMA flowchart of the article selection process. حسب Renáta Kiss-Miki (20760127)

الموضوعات:

Forest plot showing the ratio of odds of hypothyroidism (=event) among pediatric brain cancer patients treated with either PT or XRT. حسب Renáta Kiss-Miki (20760127)

الموضوعات:

Forest plot showing the odds of 5-year overall-survival rate among children with brain tumors treated with either PT or XRT. حسب Renáta Kiss-Miki (20760127)

الموضوعات:

Data_table_with_all_identified_articles_31-JAN-2025. حسب Renáta Kiss-Miki (20760127)

الموضوعات:

Forest plot showing the ratio of odds of grade 3 anemia (=event) among pediatric patients with brain tumors treated with either PT or XRT. حسب Renáta Kiss-Miki (20760127)

الموضوعات: